On March 25, 2022, Carl Sandler provided notice of his resignation as a member of the Board of Directors of Enochian Biosciences Inc. to focus on his other business ventures, with such resignation being effective March 25, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.64 USD | +13.10% |
|
+27.13% | -48.26% |
14/06 | Renovaro Says Investors Commit $10 Million Additional Equity | MT |
24/05 | Renovaro, Amsterdam UMC Cancer Center Plan to Form Joint Venture for Cancer Immunotherapy | MT |
1st Jan change | Capi. | |
---|---|---|
-48.26% | 24Cr | |
+18.15% | 12TCr | |
+18.02% | 11TCr | |
+5.07% | 2.29TCr | |
-12.75% | 2.22TCr | |
-9.86% | 1.7TCr | |
-14.97% | 1.69TCr | |
-39.94% | 1.69TCr | |
+2.80% | 1.36TCr | |
+27.39% | 1.16TCr |
- Stock Market
- Equities
- RENB Stock
- News Renovaro Inc.
- Enochian Biosciences, Inc. Announces Resignation of Carl Sandler as Member of the Board of Directors